NRC HEALTH Operating Income Loss

Quick Answer

NRC HEALTH reported Operating Income Loss of $22.59 million for the year ending 2025.

  • NRC HEALTH showed a decrease of -35.8% in Operating Income Loss from 2024 to 2025.
  • This data is from NRC HEALTH's annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2010: $2.66 million | Q3 2010: $3.49 million | Q1 2011: $5.70 million | Q2 2011: $3.83 million | Q3 2011: $4.19 million | Q1 2012: $6.08 million | Q2 2012: $5.22 million | Q3 2012: $5.65 million | Q1 2013: $7.22 million | Q2 2013: $5.53 million | Q3 2013: $6.03 million | Q1 2014: $8.40 million | Q2 2014: $6.32 million | Q3 2014: $7.16 million | Q1 2015: $5.83 million | Q2 2015: $6.36 million | Q3 2015: $6.55 million | Q1 2016: $8.01 million | Q2 2016: $7.02 million | Q3 2016: $7.34 million | Q1 2017: $9.98 million | Q2 2017: $8.45 million | Q3 2017: $7.12 million | Q1 2018: $8.96 million | Q2 2018: $7.76 million | Q3 2018: $9.17 million | Q1 2019: $10.70 million | Q2 2019: $10.15 million | Q3 2019: $10.22 million | Q1 2020: $11.19 million | Q2 2020: $9.28 million | Q3 2020: $12.02 million | Q1 2021: $12.02 million | Q2 2021: $12.24 million | Q3 2021: $13.14 million | Q1 2022: $11.70 million | Q2 2022: $11.50 million | Q3 2022: $11.11 million | Q1 2023: $9.02 million | Q2 2023: $9.37 million | Q3 2023: $9.96 million | Q1 2024: $8.76 million | Q2 2024: $8.87 million | Q3 2024: $7.98 million | Q1 2025: $8.60 million | Q2 2025: $1.59 million | Q3 2025: $7.74 million.
  • Over the full 17 years of available data (2009 to 2025), NRC HEALTH's Operating Income Loss has grown by 64.9%.
  • Historical annual values: Fiscal year 2025: $22.59 million | Fiscal year 2024: $35.19 million | Fiscal year 2023: $40.05 million | Fiscal year 2022: $46.54 million | Fiscal year 2021: $50.27 million | Fiscal year 2020: $42.68 million | Fiscal year 2019: $43.04 million | Fiscal year 2018: $35.28 million | Fiscal year 2017: $34.22 million | Fiscal year 2016: $31.20 million | Fiscal year 2015: $26.45 million | Fiscal year 2014: $28.30 million | Fiscal year 2013: $24.81 million | Fiscal year 2012: $22.72 million | Fiscal year 2011: $18.74 million | Fiscal year 2010: $13.86 million | Fiscal year 2009: $13.70 million.
  • Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: